Bei-li Lu
7 Papers
Bei-li Lu is an academic researcher. The author has contributed to research in topics: Medicine & In vivo. The author has co-authored 1 publications.
Chat about Author
Papers
Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy.
Fan Zhuang,Qiong Ma,Caihong Dong,Huijing Xiang,Yujia Shen,Pei Sun,Cuixian Li,Yi-xin Chen,Bei-li Lu,Yu Chen,Bei-jian Huang +10 more
TL;DR: This work provides a distinctive insight into the exploitation of the hypoxia-activated sonochemotherapeutic nanoprodrug that utilizes the hypoxic condition in TME, a side effect of SDT, to initiate chemotherapy, thus causing a significantly augmented treatment outcome compared to conventional SDT.
67
3D-CEUS tracking of injectable chemo-sonodynamic therapy-enabled mop-up of residual renal cell carcinoma after thermal ablation
Cuixian Li,Piao-xia Zhu,Huijing Xiang,Yunjie Jin,Bei-li Lu,Yu-Jia Shen,Wei Wang,Bei-jian Huang,Yu Chen +8 more
TL;DR: In this article , the authors reported an injectable thermosensitive hydrogel by confining curcumin (Cur)-loaded hollow mesoporous organosilica nanoparticles, which can locate in tumor site more than half a month and mop up the residual RCC under ultrasound (US) irradiation after transforming from colloidal sol status to elastic gel matrix at physiological temperature.
9
Comparison of contrast-enhanced ultrasound, IOTA simple rules and O-RADS for assessing the malignant risk of sonographically appearing solid ovarian masses.
TL;DR: In this paper , the diagnostic accuracy of ovarian solid tumors by 2D ultrasound and contrast-enhanced ultrasound (CEUS) was explored, and the authors retrospectively evaluated the CEUS characteristics of prospectively enrolled 16 benign and 19 malignant ovarian solid tumor.
3
Engineering Photothermal Catalytic CO2 Nanoreactor for Osteomyelitis Treatment by In Situ CO Generation.
Zhuang Fan,Luxia Jing,Huijing Xiang,Cuixian Li,Bei-li Lu,Lixia Yan,Jingjing Wang,Yu Chen,Bei-jian Huang +8 more
TL;DR: This study represents the first attempt to develop high-performance photothermal CO2 nanocatalysts to achieve in situ CO generation for the concurrent inhibition of bacterial growth and attenuation of inflammatory responses.
3